What's with the recent flurry of consolidation in #DigitalHealth? My new penpals, @healthbjk & Ben Lee, jotted down some thoughts here. bit.ly/3r90E1I #healthtech #venture #healthcare #startup

Often cast aside by #VCs, Professional Services can actually be essential to building a high-growth, stick #SaaS business link.medium.com/E3q6rfl6xpb H/T 8VC

This is graph (via Tomasz Tunguz) is exactly what every #startup and #vc should be thinking about right now buff.ly/38sg2Aa #tech

Demonstrating clinical outcomes in #healthcare is a key hurdle to gaining payor validation (and $$$)! via Morgan Cheatham, MD buff.ly/3NrRVAE

Having survived two previous market resets (2001, 2009), people frequently ask me how this 2022 market reset is different and how it is the same. The obvious similarity is that valuation multiples have collapsed. We went from a "glass very full" mindset to one with many concerns.

Not all tech-enabled services are equal in #healthcare. Great post from the team Greycroft buff.ly/3z4Mxxy

Extremely excited to be partnering again with Kirk Simpson + Peter Carrescia on Qui Identity and the next generation of digital identity! buff.ly/3btJQ0z

So excited to finally announce our ticket aboard the Abridge 🚀! #tech #healthcare #venture

Come join our team Wittington Ventures!

+1!

🔥

This is a huge milestone for the clinical trial space - congrats to the Unlearn.AI team! 🔥🚀 #healthTech #clinicaltrials

Watch out for Gatik's driverless trucks in Toronto! Making history in Canada =) 🛻 🚐 🇨🇦

🤯

Synthetic biology in beauty? It's happening and the potential is enormous. Check out Qasim Mohammad's piece on why it matters buff.ly/3WThIXN #synbio #VC

🔥 Excited to see Abridge and Memorial Sloan Kettering Cancer Center partnership come to life!

This is useful!

It's always "wartime" for a #startup. It's the fundamental nature of being cash flow negative. @charleskfisher penned an excellent call to arms to his troops at Unlearn.AI. Take a read...

With the addition of leading researcher Dr. Zachary Lipton as Chief Science Officer, Abridge continues to validate its approach to using cutting edge NLP + LLMs to transform clinical documentation in #healthcare 👏 🚀 buff.ly/3YQuYfR

Smaller Trials for Bigger Impact! Excited to announce Wittington Ventures's investment in Unlearn.AI's series B-1 investment round. Unlearn is transforming the clinical trial landscape through digital twins and we're excited be a part of the jounrey 🚀 buff.ly/3FV3Zso